Seed · Medtech & Devices · Espoo, Finland · Founded 2022 · 12–12 employees
Fepod develops a revolutionary point-of-care blood diagnostics platform that measures paracetamol, opioids and other pain medicine concentrations from a single drop of blood in under one minute. Their electrochemical testing system uses a smartphone, portable potentiostat and disposable sensors, delivering lab-grade results at the point-of-care. The company has completed clinical trials at Turku University Hospital and received ISO 13485 certification. Backed by Almaral Oy with €750,000 in seed funding and supported by Business Finland grants, Fepod is focused on regulatory approvals and commercial launch in acute care markets.
No open roles listed right now.